Small cell lung cancer
Small cell lung cancer (SCLC) accounts for about 20% of lung cancer. It is highly malignant, has a short doubling time, early and extensive metastasis, is sensitive to chemotherapy and radiotherapy, and has a high initial remission rate. However, it is very prone to secondary drug resistance and relapse. Treatment is mainly systemic chemotherapy.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
Middle-aged smokers are more likely to -
Related symptoms:
Fatigue cough shortness of breath weight loss
Related Drugs
Docetaxel Injection
Indication: 1. It is suitable for the treatment of locally advanced or metastatic breast cancer. 2. It is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer, even after the failure of cisplatin-based chemotherapy.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.
Docetaxel Injection
Indication: 1. It is suitable for the treatment of locally advanced or metastatic breast cancer. 2. It is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer, even after the failure of cisplatin-based chemotherapy.
Manufacturer:
Beijing Eastern Union Biopharmaceuticals, Ltd.
Docetaxel Injection
Indication: 1. Docetaxel is suitable for the treatment of advanced or metastatic breast cancer after failure of previous chemotherapy. Unless it is clinically contraindicated, previous treatment should include anthracycline anticancer drugs. 2. Docetaxel is suitable for the treatment of advanced or metastatic non-small cell lung cancer after failure of chemotherapy based on cisplatin.
Gemcitabine Hydrochloride
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.
Gemcitabine Hydrochloride
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Lianyungang JARI Pharmaceutical Co., Ltd.
Teniposide Injection
Indication: This product is suitable for the treatment of the following diseases, usually in combination with other anticancer drugs: malignant lymphoma; Hodgkin's disease; acute lymphocytic leukemia, high-risk cases in adults and children; intracranial malignancies: glioblastoma, vascular dysplasia, astrocytoma; bladder cancer; neuroblastoma and other solid tumors in children.
Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Nanjing Chia Tai-tianqing Pharmaceutical Co., Ltd.
Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Lianyungang JARI Pharmaceutical Co., Ltd.
Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.